Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Immucell (ICCC) Receivables - Other (2016 - 2025)

Immucell's Receivables - Other history spans 16 years, with the latest figure at $31177.0 for Q4 2025.

  • For Q4 2025, Receivables - Other fell 23.12% year-over-year to $31177.0; the TTM value through Dec 2025 reached $31177.0, down 23.12%, while the annual FY2025 figure was $31177.0, 23.12% down from the prior year.
  • Receivables - Other reached $31177.0 in Q4 2025 per ICCC's latest filing, down from $54341.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.1 million in Q2 2021 to a low of $6101.0 in Q2 2023.
  • Average Receivables - Other over 5 years is $1.1 million, with a median of $48771.5 recorded in 2024.
  • The largest YoY upside for Receivables - Other was 82867.3% in 2023 against a maximum downside of 99.88% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $55490.0 in 2021, then decreased by 23.99% to $42178.0 in 2022, then dropped by 5.8% to $39733.0 in 2023, then grew by 2.07% to $40555.0 in 2024, then dropped by 23.12% to $31177.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Receivables - Other are $31177.0 (Q4 2025), $54341.0 (Q3 2025), and $44913.0 (Q2 2025).